Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia

PURPOSE: Dasatinib is effective therapy for chronic myeloid leukemia (CML) after imatinib failure. In this study, we investigate the efficacy of dasatinib as initial therapy for patients with CML in early chronic phase. PATIENTS AND METHODS: Patients with newly diagnosed CML in early chronic phase w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Cortes, Jorge E., Jones, Dan, O'Brien, Susan, Jabbour, Elias, Ravandi, Farhad, Koller, Charles, Borthakur, Gautam, Walker, Brenda, Zhao, Weiqiang, Shan, Jianqin, Kantarjian, Hagop
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2010
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2815702/
https://ncbi.nlm.nih.gov/pubmed/20008620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.25.4920
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi